Average Insider

Where insiders trade, we follow

Insider Buy/Sell Details for the Healthcare Sector — Last 30 Days

Extreme outlier transactions (>3σ) are excluded.Show All Data
Ratio0.1:1
Daily Buy & Sell Volume
Sep 3, 2026
Sale
Shares
4,600
Price
$80.30
Total Value
$369.38K
Shares Held After
29,062
% of Holdings
13.7%

UNITED THERAPEUTICS Corp (UTHR)

MAHON PAUL A — EVP&GENERAL COUNSEL
Sep 3, 2026
Sale
Shares
320
Price
$490.88
Total Value
$157.08K
Shares Held After
45,172
% of Holdings
0.7%

UNITED THERAPEUTICS Corp (UTHR)

MAHON PAUL A — EVP&GENERAL COUNSEL
Sep 3, 2026
Sale
Shares
10
Price
$488.32
Total Value
$4.88K
Shares Held After
45,492
% of Holdings
0.0%

UNITED THERAPEUTICS Corp (UTHR)

MAHON PAUL A — EVP&GENERAL COUNSEL
Sep 3, 2026
Sale
Shares
169
Price
$487.36
Total Value
$82.36K
Shares Held After
45,502
% of Holdings
0.4%

UNITED THERAPEUTICS Corp (UTHR)

MAHON PAUL A — EVP&GENERAL COUNSEL
Sep 3, 2026
Sale
Shares
598
Price
$486.47
Total Value
$290.91K
Shares Held After
45,671
% of Holdings
1.3%

UNITED THERAPEUTICS Corp (UTHR)

MAHON PAUL A — EVP&GENERAL COUNSEL
Sep 3, 2026
Sale
Shares
954
Price
$485.12
Total Value
$462.81K
Shares Held After
46,269
% of Holdings
2.0%

UNITED THERAPEUTICS Corp (UTHR)

MAHON PAUL A — EVP&GENERAL COUNSEL
Sep 3, 2026
Sale
Shares
200
Price
$483.85
Total Value
$96.77K
Shares Held After
47,223
% of Holdings
0.4%

UNITED THERAPEUTICS Corp (UTHR)

MAHON PAUL A — EVP&GENERAL COUNSEL
Sep 3, 2026
Sale
Shares
160
Price
$482.66
Total Value
$77.23K
Shares Held After
47,423
% of Holdings
0.3%

UNITED THERAPEUTICS Corp (UTHR)

MAHON PAUL A — EVP&GENERAL COUNSEL
Sep 3, 2026
Sale
Shares
1,048
Price
$481.92
Total Value
$505.05K
Shares Held After
47,583
% of Holdings
2.2%

UNITED THERAPEUTICS Corp (UTHR)

MAHON PAUL A — EVP&GENERAL COUNSEL
Sep 3, 2026
Sale
Shares
2,360
Price
$480.86
Total Value
$1.13M
Shares Held After
48,631
% of Holdings
4.6%

UNITED THERAPEUTICS Corp (UTHR)

MAHON PAUL A — EVP&GENERAL COUNSEL
Sep 3, 2026
Sale
Shares
936
Price
$479.66
Total Value
$448.96K
Shares Held After
50,991
% of Holdings
1.8%

UNITED THERAPEUTICS Corp (UTHR)

MAHON PAUL A — EVP&GENERAL COUNSEL
Sep 3, 2026
Sale
Shares
1,545
Price
$478.93
Total Value
$739.95K
Shares Held After
51,927
% of Holdings
2.9%

ILLUMINA, INC. (ILMN)

Meister Keith A. — Director
Sep 2, 2026
Sale
Shares
10,620
Price
$213.73
Total Value
$2.27M
Shares Held After
965,802
% of Holdings
1.1%

ILLUMINA, INC. (ILMN)

Meister Keith A. — Director
Sep 2, 2026
Sale
Shares
57,488
Price
$213.20
Total Value
$12.26M
Shares Held After
976,422
% of Holdings
5.6%

Evolus, Inc. (EOLS)

MOATAZEDI DAVID — Director
Sep 2, 2026
Sale
Shares
105,108
Price
$9.04
Total Value
$950.02K
Shares Held After
499,592
% of Holdings
17.4%

Ceribell, Inc. (CBLL)

Blumberg Scott — Chief Financial Officer
Sep 2, 2026
Sale
Shares
652
Price
$25.00
Total Value
$16.30K
Shares Held After
146,600
% of Holdings
0.4%

Ceribell, Inc. (CBLL)

Chao Xingjuan — Director
Sep 2, 2026
Sale
Shares
39,540
Price
$24.61
Total Value
$973.08K
Shares Held After
767,191
% of Holdings
4.9%
Sep 2, 2026
Sale
Shares
615
Price
$23.74
Total Value
$14.60K
Shares Held After
19,686
% of Holdings
3.0%
Sep 2, 2026
Sale
Shares
10,824
Price
$22.85
Total Value
$247.33K
Shares Held After
20,301
% of Holdings
34.8%
Shares
42,129
Price
$3.11
Total Value
$131.22K
Shares Held After
11,521,296
% of Holdings
0.4%

Heartflow, Inc. (HTFL)

Verghese Vikram — Chief Financial Officer
Sep 2, 2026
Sale
Shares
5,876
Price
$50.60
Total Value
$297.33K
Shares Held After
248,683
% of Holdings
2.3%

Alector, Inc. (ALEC)

Wong-Sarad Grace — Principal Accounting Officer
Sep 2, 2026
Sale
Shares
656
Price
$2.75
Total Value
$1.80K
Shares Held After
114,805
% of Holdings
0.6%

LifeStance Health Group, Inc. (LFST)

Paunovich Vukasin — Chief Technology Officer
Sep 2, 2026
Sale
Shares
42,067
Price
$12.87
Total Value
$541.40K
Shares Held After
205,379
% of Holdings
17.0%
Sep 2, 2026
Sale
Shares
22,500
Price
$23.35
Total Value
$525.38K
Shares Held After
6,504,133
% of Holdings
0.3%
Sep 2, 2026
Sale
Shares
22,500
Price
$23.35
Total Value
$525.38K
Shares Held After
6,504,133
% of Holdings
0.3%

IQVIA HOLDINGS INC. (IQV)

Berkshire James G. — EVP, Global Infrastructure and Operations. Power of Attorney
Sep 2, 2026
Sale
Shares
2,668
Price
$261.33
Total Value
$697.23K
Shares Held After
10,890
% of Holdings
19.7%

Axogen, Inc. (AXGN)

TYNDALL JOSEPH A. — Director
Sep 2, 2026
Sale
Shares
3,500
Price
$49.70
Total Value
$173.94K
Shares Held After
10,650
% of Holdings
24.7%
Sep 2, 2026
Sale
Shares
391
Price
$27.12
Total Value
$10.60K
Shares Held After
35,559
% of Holdings
1.1%
Sep 2, 2026
Sale
Shares
2,800
Price
$26.38
Total Value
$73.85K
Shares Held After
35,950
% of Holdings
7.2%
Sep 2, 2026
Sale
Shares
313
Price
$157.00
Total Value
$49.14K
Shares Held After
250
% of Holdings
55.6%
Sep 2, 2026
Sale
Shares
1,375
Price
$27.12
Total Value
$37.29K
Shares Held After
38,773
% of Holdings
3.4%
Sep 2, 2026
Sale
Shares
9,852
Price
$26.38
Total Value
$259.86K
Shares Held After
40,148
% of Holdings
19.7%
Sep 2, 2026
Sale
Shares
15,000
Price
$1.41
Total Value
$21.15K
Shares Held After
208,391
% of Holdings
6.7%

Butterfly Network, Inc. (BFLY)

Caezza Nicholas — Deputy General Counsel
Sep 2, 2026
Sale
Shares
1,709
Price
$8.15
Total Value
$13.93K
Shares Held After
305,166
% of Holdings
0.6%
Sep 2, 2026
Sale
Shares
30,000
Price
$10.58
Total Value
$317.40K
Shares Held After
775,559
% of Holdings
3.7%
Sep 2, 2026
Sale
Shares
18,500
Price
$35.12
Total Value
$649.64K
Shares Held After
235,244
% of Holdings
7.3%

Maze Therapeutics, Inc. (MAZE)

Bernstein Harold — President, R&D&CMO
Sep 2, 2026
Sale
Shares
625
Price
$27.12
Total Value
$16.95K
Shares Held After
14,894
% of Holdings
4.0%

Maze Therapeutics, Inc. (MAZE)

Bernstein Harold — President, R&D&CMO
Sep 2, 2026
Sale
Shares
4,481
Price
$26.38
Total Value
$118.19K
Shares Held After
15,519
% of Holdings
22.4%
Sep 2, 2026
Sale
Shares
22,500
Price
$23.35
Total Value
$525.38K
Shares Held After
6,504,133
% of Holdings
0.3%

Maze Therapeutics, Inc. (MAZE)

Courtney Phillips — GC and Corp. Secretary
Sep 2, 2026
Sale
Shares
243
Price
$27.12
Total Value
$6.59K
Shares Held After
9,019
% of Holdings
2.6%

Maze Therapeutics, Inc. (MAZE)

Courtney Phillips — GC and Corp. Secretary
Sep 2, 2026
Sale
Shares
1,738
Price
$26.38
Total Value
$45.84K
Shares Held After
9,262
% of Holdings
15.8%

ARTIVION, INC. (AORT)

GREEN ANDREW M — SVP, Regulatory and Quality
Sep 2, 2026
Sale
Shares
6,510
Price
$27.27
Total Value
$177.50K
Shares Held After
53,133
% of Holdings
10.9%

JOHNSON&JOHNSON (JNJ)

Schmid Timothy — EVP, WW Chair, MedTech
Sep 2, 2026
Sale
Shares
22,527
Price
$274.74
Total Value
$6.19M
Shares Held After
25,447
% of Holdings
47.0%

JOHNSON&JOHNSON (JNJ)

Schmid Timothy — EVP, WW Chair, MedTech
Sep 2, 2026
Sale
Shares
11,070
Price
$274.74
Total Value
$3.04M
Shares Held After
25,447
% of Holdings
30.3%

AtriCure, Inc. (ATRC)

Privitera Salvatore — Chief Technical Officer
Sep 2, 2026
Sale
Shares
7,763
Price
$52.50
Total Value
$407.56K
Shares Held After
150,921
% of Holdings
4.9%

RESMED INC (RMD)

FARRELL PETER C — Director
Sep 2, 2026
Sale
Shares
970
Price
$234.73
Total Value
$227.69K
Shares Held After
51,803
% of Holdings
1.8%

Autolus Therapeutics plc (AUTL)

Piccina Cintia — U.S. CCO&Country Gen Manager
Sep 2, 2026
Sale
Shares
6,713
Price
$2.34
Total Value
$15.68K
Shares Held After
13,287
% of Holdings
33.6%

Tarsus Pharmaceuticals, Inc. (TARS)

Lin Elizabeth Yeu — Chief Medical Officer
Sep 2, 2026
Sale
Shares
1,590
Price
$80.00
Total Value
$127.20K
Shares Held After
4,770
% of Holdings
25.0%

Tarsus Pharmaceuticals, Inc. (TARS)

Lin Elizabeth Yeu — Chief Medical Officer
Sep 2, 2026
Sale
Shares
5,387
Price
$80.00
Total Value
$430.96K
Shares Held After
13,320
% of Holdings
28.8%

Ascendis Pharma A/S (ASND)

HOLTUG LARS — Director
Sep 2, 2026
Sale
Shares
236
Price
$264.13
Total Value
$62.33K
Shares Held After
4,000
% of Holdings
5.6%
Version: v26.9.1